Professor Mark Beresford is a Consultant Clinical Oncologist at the Dyson Cancer Centre, Royal United Hospital Bath and has a Visiting Chair at the University of Bath. He specialises in the treatment of breast and urological cancers. He is a graduate of both Cambridge and Oxford Universities and undertook his specialist oncology training in London (UCLH, Charing Cross and Mount Vernon Hospitals).
Professor Beresford has a DM from Oxford University for research into the assessment of response to chemotherapy using functional imaging techniques. He is author of over 60 peer-reviewed publications and is Chief Investigator on numerous national and international clinical trials.
Professor Beresford advises NICE at scoping meetings and Technology Appraisals. He is a member of the Clinical Oncology Professional Support and Standards Board for the Royal College of Radiologists and chairs the RCR Management for Oncologists course. He is a committee member of the British Uro-oncology Group (BUG) and Cancer Research @ Bath. He chairs the West of England Breast Cancer Site Specific Group, is Cancer Research Lead for the South West and has served two terms as vice-chair of the CRUK Population Research Committee. He is co-founder and co-chair of the UK Breast Cancer Group (UKBCG).